What Does Becton, Dickinson’s Debt Look Like?
Shares of Becton, Dickinson (NYSE:BDX) moved lower by 6.03% in the past three months. Before having a look at the importance of debt, let us look at how much debt Becton, Dickinson has.
10 Biggest Price Target Changes For Wednesday
Guggenheim cut the price target on The Kraft Heinz Company (NASDAQ: KHC) from $46 to $33. Kraft Heinz shares fell 1.2% to $34.10 in pre-market trading.
Piper Sandler Downgrades Becton, Dickinson to Neutral, Lowers Price Target to $260
Piper Sandler analyst William Quirk downgrades Becton, Dickinson (NYSE:BDX) from Overweight to Neutral and lowers the price target from $285 to $260.
BD Selects “embecta” As Name Of New Company For Planned Spinoff Of Diabetes Care Business
BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, today announced that "embecta" [pronounced em-BECK-tah] will be the name of the independent, publicly-traded
This Foreboding Sign Looms Over Becton, Dickinson’s Chart
If history is any guide, there may be trouble ahead for shares of Becton, Dickinson (NYSE:BDX). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.
Qiagen, Becton Dickinson Settle Patent Infringement Lawsuit For $53M
Qiagen N.V. (NYSE:QGEN) settled with Becton Dickinson & Co (NYSE:BDX) a patent infringement lawsuit related to Qiagen’s NeuMoDx 96 and NeuMoDx 288 clinical…
Becton Q4 Adj. EPS $2.59 Beats $2.46 Estimate, Sales $5.13B Beat $4.91B Estimate
Becton (NYSE:BDX) reported quarterly earnings of $2.59 per share which beat the analyst consensus estimate of $2.46 by 5.28 percent. This is a 7.17 percent decrease over earnings of $2.79 per share from the same period
Earnings Scheduled For November 4, 2021
Companies Reporting Before The Bell
• DISH Network (NASDAQ:DISH) is likely to report quarterly earnings at $0.91 per share on revenue of $4.45 billion.
Becton Dickinson Inks BARDA Contract For Five Combo Assays
Becton Dickinson & Co (NYSE:BDX) has formed a public-private partnership with the Biomedical Advanced Research and Development Authority (BARDA) to develop…